跳至主要内容
临床试验/NCT06466824
NCT06466824尚未招募不适用

Observational Study on the Outcome of Patients With Primary Immune Thrombocytopenia (ITP) Who Underwent Splenectomy After January 1st, 2010

Gruppo Italiano Malattie EMatologiche dell'Adulto0 个研究点目标入组 157 人开始时间: 2024年9月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
157
主要终点
evaluation of complications' incidence after splenectomy

研究概览

简要总结

Retrospective data collection on ITP patients who underwent splenectomy from 01/01/2010 to 12/31/2022. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

详细描述

Observational, longitudinal, retrospective study on ITP patients. Patients with ITP who underwent splenectomy from 01/01/2010 to 12/31/2022 will be enrolled. All useful data will be collected exclusively through consultation of outpatient medical records. The expected enrollment period is 6 months. The observation period of the enrolled patients is at least 1 year.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged ≥ 18 years
  • Patients with primary ITP according to international criteria [2], who underwent to splenectomy from 01/01/2010 to 12/31/
  • Obtaining Informed Consent.

排除标准

  • 未提供

结局指标

主要结局

evaluation of complications' incidence after splenectomy

时间窗: at 90 days

Determine the percentage and incidence of thrombotic, hemorrhagic and infectious complications occurring during the patient's follow-up

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验